The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer

E. Boven, H. Schipper, C.A.M. Erkelens, S.A. Hatty, H.M. Pinedo

Research output: Contribution to journalArticleAcademicpeer-review

53 Downloads (Pure)
Original languageEnglish
Pages (from-to)52-62
JournalBritish Journal of Cancer
Volume68
Publication statusPublished - 1993

Cite this